Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"The Weed Blog" had published this article of NXEN:
https://cannabismaven.io/theweedblog/science/cannabinoid-based-treatment-for-patients-with-myotonic-dystrophies-and-myotonia-bMXoFmGmDEGXN845TPFw4Q/
$NXEN - MUST LISTEN! CEO Audio Interview with WallstreetReporter.com
http://www.wallstreetreporter.com/2018/11/nexien-biopharma-inc-otc-nxen-developing-a-cannabinoid-based-drug-pipeline/
Sign-up for a FREE account and have a listen. You'll see why now is the time to pickup shares while, IMO, a private placement investor who had shares locked up since June 2017 is selling -- mind you, they are making a profit at $0.35.
Again, ONLY 4.9M FLOAT!, Cannabinoid-based Drugs, Patent Applications, FDA Applications in, etc.
$NXEN - MUST LISTEN! CEO Audio Interview with WallstreetReporter.com
http://www.wallstreetreporter.com/2018/11/nexien-biopharma-inc-otc-nxen-developing-a-cannabinoid-based-drug-pipeline/
Sign-up for a FREE account and have a listen. You'll see why now is the time to pickup shares while, IMO, a private placement investor who had shares locked up since June 2017 is selling -- mind you, they are making a profit at $0.35.
Again, ONLY 4.9M FLOAT!, Cannabinoid-based Drugs, Patent Applications, FDA Applications in, etc.
$NXEN - MUST LISTEN! CEO Audio Interview with WallstreetReporter.com
http://www.wallstreetreporter.com/2018/11/nexien-biopharma-inc-otc-nxen-developing-a-cannabinoid-based-drug-pipeline/
Sign-up for a FREE account and have a listen. You'll see why now is the time to pickup shares while, IMO, a private placement investor who had shares locked up since June 2017 is selling -- mind you, they are making a profit at $0.35.
Again, ONLY 4.9M FLOAT!, Cannabinoid-based Drugs, Patent Applications, FDA Applications in, etc.
I hope the weak ass Private Placement Investor that's dumping now... Is all out of shares before the news. They don't deserve more than $0.35/share.
Hope folks see the light and keep accumulating.
Float: 4,917,833 as of today.
Amen, sir. Welcome.
Orphan Drug SHOULD allow for that $500M+ Market Cap run (~$10). Further, official FDA approval of course would be even more bonkers. GWPH is the proof of that.
I hate making statements like that, but it's my honest opinion based on other companies having done it AND most importantly, I'm saying it CAN happen with the right news.
It can actually happen because of dishonest people pumping too, but never the less... Knowing the difference between a no-facts pumper and an excited shareholder can be important.
I'm being transparent enough that I'm saying I WILL take profits if we see $9+ ... Based on Market Cap, which I know in trading OTC garbage stocks means nothing. But, with a legit Biotech, I feel it has some relevance.
My profit-taking strategy will be based around news and updates. Again, unless we have a wild run not based on facts and news then I will profit take because it just is smart to think we will see a large dip after that kind of unnecessary run.
Me as well. Holding for SEVERAL dollars... Purely thinking of what OWCP, CNBX, and AXIM ran to last year and thinking NXEN seems like they're onto a couple big things already... Wheels in motion dating back to earlier 2017 too.
Reminder, those other stocks all ran to Market Caps over $430M (one to over $700M). Plus, we know GWPH had a $3B market cap before FDA approval.
While NXEN may not have full blown FDA approval for a while, even being granted Orphan Drug designation could be a huge deal.
$500M Market Cap here is over $9, mind you.
Jeffrey himself doesn't have shares, but his wife, son, and daughter do.
Right. So, that's what I mean, the S-1 that was filed on 6/19/2018 showed 16,613,536 total shares being owned by that list of people.
But some of the biggest shareholders on that list were "Insiders" like Alain Bankier, Robert Goldfarb, and Mark Lubchenco & family to name a few.
H. Leigh Severance has 1.32M shares but he's a Fund Manager since 1984 in Denver -- so I would suspect he wasn't going to rush into selling either.
Anyway. Whatever, right? :)
I'm being patient as I feel quite confident these guys are on the right track behind the scenes based on their 10-K, 8-Ks, and PRs to date.
I knoooow it sucks to see an account in the red -- and mine is currently too. But it won't last, IMHO.
MOST of their shares became unrestricted, minus the $0.38 Warrants as those would become unrestricted in December.
Only the new management has theirs restricted for a year now.
The thing is, a lot of the original Private Placement guys aren't necessarily in a hurry to transfer shares to a broker. People like Alain Bankier (CSO) and Richard Greenberg were PP Investors. I'd be surprised if they're transferring to a broker any time soon.
The very first private placement people, perhaps. And, again, their shares were restricted from June 2017 - October 2018 because the SEC Filing didn't happen until October 2017 finally and they had to wait 12 months from then.
Still a Return at $0.28 -- but damn, these guys can see far greater returns if they just wait for another announcement or so.
I've learned many people lack patience or "settle" to easily.
If it doesn't... I think I give up on trying to figure out the OTC. Haha.
People are always getting garbage stocks with hundreds of millions or even billions of shares to run wild on B.S. speculation before they even file with the SEC.
Then you find something with NXEN where it's not just speculation, but actually easy to prove thanks to SEC filings, PRs, etc. and they shy away.
*shrug*
I just wonder who has picked up the last 1.3 million shares...
Right. I don't know what the hold up is here.
I see pure garbage stocks run all the time. Most recently, I point out RCGP ran to a $1.6 BILLION market cap because ONE of the owners had a successful track record and because they were going to launch a CBD company -- supposedly.
Well, NXEN has a frickin' LIST of proven management, not just a single person. Plus, some of these guys have the PHARMA experience.
I don't get it, but I'm not going to be "pushing it" on people. Whatever. It'll run when it runs and people can whine about not buying at $0.32 when they could.
I pray OWCP runs nicely this week thanks to MJBizCon -- I may sell SOME more and buy more NXEN at 0.32... It's a steal, IMO.
Private Placement investors buy shares usually get a discount on their first round of shares, but because they're also restricted for at least 6 months... They also get bonus FUTURE incentives to be able to PURCHASE additional shares at a fixed rate in the future.
The company is able to raise capital via selling restricted shares.
Nobody in their right mind will exercise their $1.00 warrant unless the share price is OVER $1.00 by end of November.
But, if the stock runs to $5.00 by January... They'll probably buy their $2.00 Warrants and the proceeds go directly to the company as new capital.
Yeah, I'm BAFFLED people aren't buying more. But, unfortunately some bought much higher up and don't want to "average down" because they panic too soon.
Honestly, based on the very obvious DD -- how would this stock NOT climb back over $1.00 once people catch on?
Management is the key factor... A list of successful people onboard. They're GOING to make things happen, but in the world of BioPharma, it sometimes takes a little patience.
They've been making moves for over a year behind the scenes (when they were privately held), so it's not like this is a pure start-up either. It's just newly Public.
I use https://www.nasdaq.com/symbol/nxen/historical as a means of showing all of the data in terms of Open, High, Low, Closed, and Volume.
I did the math myself -- total volume over those days.
The last two trades of the day were at 15:52:20 and 15:52:37 for 7,500 and 3,200 respectively.
Gobble, Gobble.
IMO, they (original Intiva guys) care about shareholders, but they just know this is an investment grade company (that even they invested in back in the beginning) and they know material news and updates will spark big returns.
Most of them have been with big, successful companies for years leading up to a buyout.
Ditto, sir. No selling, only buying.
I have no interest in selling unless we see a big run. Definitely not "settling". Patience will pay.
Maybe you'll be lucky enough to average down a bit more over the next week or whatever. Who knows how long until the sellers are done. Could be done ANY day too though. Nobody could ever know.
Obviously if we had some good updates, it won't matter because volume will go much higher and there will be Ask slapping then.
But, at the end of the day... $0.80 is "only" a ~$44.36M Market Cap.
CNBX is around $70M right now and AXIM is around $82M. Those two also had huge runs on news, so hopefully we can have the same fun experience here.
Any day/week/month. *shrug*
We're up to 1.25M shares accumulated now. Hopefully those short-sighted sellers are about out of shares.
Not crazy at all. Wish I had waited.. Just figured with all this company has going on we'd have seen a wild run.
Why RCGP did and NXEN hasn't is mind-blowing.
Based on the other email addresses, I assume Alex Wasyl would be awasyl@nexienbiopharma.com... Reach out.
He may have a shareholder update planned soon. Who knows. Obviously they won't tell you any material updates.
I would LOVE to know who is that impatient and selling.
Again, I feel it has to be an original Private Placement investor who, after 1.5 years, just wants their 100% return - or whatever.
But, once they're done... They'll see what they missed out on. Company hasn't even really begun with updates and progress. Literally just finalized the CRx Bio Holdings stuff for crying out loud.
DMA board?
0.33 is a nice entry. It's a shame some got in over 0.60 and 0.80 and haven't added more to average down.
I already see some Tweets of the impatient who almost make themselves sound like Bashers, whether they know it or not.
Clearly $NXEN remains under the radar, but there have been about 1.14 million shares accumulated since the ticker change announcement on 10/18/2018.
That's a large chunk of the now 4.1 million float! Almost 28%, actually. :)
Yes, sir. I'm still hoping they have an announcement up their sleeve that sends this stock well over $1.00 so those private placement guys can exercise their warrants with pleasure! :)
Nice work. I'm probably tapped out, as I try to be somewhat diversified.
OW may see some gains again soon thanks to the MJBizCon revealing and Phase 1 data.
But, I really feel NXEN has the management to create a monster. Such a great team. I'm baffled how 'under the radar' this still is.
Nice accumulation today anyway, right? :)
$NXEN (at only $0.41) is medical cannabis with a 4.1M Float, 55.4M O/S, and a great management line-up -- SoBe Beverage co-founder, guys who have worked for Pfizer, Johnson & Johnson, Merck, and TEVA. This could easily see $5.00+ with volume/eyes/news! That'd be less than half of what OWCP and CNBX ran to last year. It'd be 1/4th of what AXIM ran to.
Plus, they filed their CSE cross-list at the end of August, which means it could be official any day.
Their 10-K talked about their treatment for Myotonic Dystrophy and Myotonia, which has a world-renowned expert as the advisor, may get FDA Orphan Drug status. They just had news about this treatment earlier in the week as well.
Lots of great things on the horizon, but the stock has just started to get going after it's R/M, then R/S, and now shares being released from a long restriction. Literally buying at the "ground level".
Some extra DD on the management at www.OwnTheFloat.com, but company website is NexienBiopharma.com with good info.
$NXEN (at $0.41) is medical cannabis with a 4.1M Float, 55.4M O/S, and a great management line-up -- SoBe Beverage co-founder, guys who have worked for Pfizer, Johnson & Johnson, Merck, and TEVA.
Plus, they filed their CSE cross-list at the end of August, which means it could be official any day.
Their 10-K talked about their treatment for Myotonic Dystrophy and Myotonia, which has a world-renowned expert as the advisor, may get FDA Orphan Drug status. They just had news about this treatment earlier in the week as well.
Lots of great things on the horizon, but the stock has just started to get going after it's R/M, then R/S, and now shares being released from a long restriction. Literally buying at the "ground level".
Some extra DD on the management at www.OwnTheFloat.com, but company website is NexienBiopharma.com with good info.
$NXEN (at $0.41) is medical cannabis with a 4.1M Float, 55.4M O/S, and a great management line-up -- SoBe Beverage co-founder, guys who have worked for Pfizer, Johnson & Johnson, Merck, and TEVA.
Plus, they filed their CSE cross-list at the end of August, which means it could be official any day.
Their 10-K talked about their treatment for Myotonic Dystrophy and Myotonia, which has a world-renowned expert as the advisor, may get FDA Orphan Drug status. They just had news about this treatment earlier in the week as well.
Lots of great things on the horizon, but the stock has just started to get going after it's R/M, then R/S, and now shares being released from a long restriction. Literally buying at the "ground level".
Some extra DD on the management at www.OwnTheFloat.com, but company website is NexienBiopharma.com with good info.
Yeah, the Private Placement investors are the only ones with enough shares at a lower cost. Hardly any shares have been picked up for under $0.35 in the last SEVERAL months, so unless people are selling at a loss... I assume it's the private placement guys selling "some" to recoup their investment from a year and a half ago. Many people have a hard time with patience. :)
I get it though, this took longer to get going than expected. But, it's finally starting to get going... So why not sit tight for another month or so? Sheesh.
But, again, whatever... I'm glad to see a new base being built around $0.50 averages. That can only help us down the road.
Exactly what I was thinking/hoping, Rooster.
We know at least 3 medical cannabis stocks -- OWCP, CNBX, and AXIM all ran wild in early 2017.
All three of those companies had higher O/S and definitely much higher Floats. Also, none of those three had such an unbelievable line-up of management.
OWCP added good people later in 2017, however.
I'm staying long here. This stupid selling will end soon enough and we'll have a much stronger base as a result.
Yup! CNBX still had a 20M Float when they ran like crazy. OWCP had closer to 80M in the Float with under 130M O/S, I believe.
Yes, I definitely think that's the case.
"Oh, well." -- right?
Those initial investors bought in back in mid-2017 and are still making a decent return at $0.43 - $0.50.
I still think it's crazy to not hold for another couple weeks when the company is just finally "getting going" in the public eye -- but as I've said before, it's almost better that they're selling NOW before the bigger news to where they'd sell at $0.75, $1.00, $1.50 to slow the run. :)
Build that new base around $0.43 - $0.58 and let those guys get 100% - 200%+.
Finally was able to login and see the action. Wow, disappointing. Why aren't people awake to NXEN yet?
I went on the Bid at $0.45 with 6,450 and immediately got 2,000 filled.
I can be patient if it means getting cheaper shares. Saved $120 on those 2,000 shares compared to the Ask. :)
Once Alex lets us know where they're at on other drug development timelines, we could definitely see some nice upward action.
Future is absolutely bright here... The only thing left to debate/speculation is "how soon" until we reach a market cap of $50M, $100M, $250M, $500M, $1B, etc.